Search
Fulcrum Therapeutics Inc
FULCAdd to Watchlist
3.725USD
-0.005-0.13%
Close 07-28 16:00（ET）Quotes delayed by 15 min
248.01MMarket Cap
LossP/E TTM
Fulcrum Therapeutics Inc's Company Valuation
Currency: USD Updated: 2026-07-28The current valuation score of Fulcrum Therapeutics Inc is 7.84, ranking 175 out of 385 in the Biotechnology & Medical Research industry. Its current P/E ratio is -3.24, which is -68.59% below the recent high of -1.02 and -38021.96% above the recent low of -1236.18.
P/E
Relevant data have not been disclosed by the company yet.
P/B
Relevant data have not been disclosed by the company yet.
P/S
Relevant data have not been disclosed by the company yet.
P/CF
Relevant data have not been disclosed by the company yet.